Monday, February 24, 2025
Happening Now

Novavax offers 1st hopeful vaccine trial data on COVID variants

U.S. company’s vaccine shows highly promising results against U.K. variant and lower, but “still pretty good” efficacy with South Africa strain. Source

Share